paroxetine has been researched along with Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capuron, L; Fuchs, D; Lawson, DH; Miller, AH; Musselman, DL; Nemeroff, CB; Neurauter, G | 1 |
Chen, S; Gao, F; Manatunga, AK | 1 |
Goodkin, RS; Greiner, K; Gumnick, JF; Lawson, DH; Manatunga, AK; Miller, AH; Musselman, DL; Nemeroff, CB; Penna, S | 1 |
Capuron, L; Gumnick, JF; Lawson, DH; Miller, AH; Musselman, DL; Nemeroff, CB; Reemsnyder, A | 1 |
3 trial(s) available for paroxetine and Melanoma
Article | Year |
---|---|
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Double-Blind Method; Female; Humans; Interferon-alpha; Kynurenine; Male; Melanoma; Middle Aged; Neopterin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Tryptophan | 2003 |
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Depressive Disorder; Disease-Free Survival; Double-Blind Method; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Paroxetine; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors | 2001 |
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Chi-Square Distribution; Double-Blind Method; Female; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Mood Disorders; Neoplasms; Paroxetine; Patients; Statistics, Nonparametric | 2002 |
1 other study(ies) available for paroxetine and Melanoma
Article | Year |
---|---|
Non-parametric estimation for baseline hazards function and covariate effects with time-dependent covariates.
Topics: Algorithms; Angiogenesis Inhibitors; Computer Simulation; Data Interpretation, Statistical; Depression; Humans; Interferon-alpha; Melanoma; Models, Statistical; Paroxetine; Patient Dropouts; Statistics, Nonparametric | 2007 |